Trial NCT04016805

View at ClinicalTrials.gov 
Org. Study IDs: UTX-TGR-208

Last trial update was posted on 2023-07-24

MeSH Interventions

Acalabrutinib Ibrutinib Venetoclax

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions

Chronic Lymphocytic Leukemia

Stopping Reasons

Strategic/Business decision

Limitations And Caveats

Due to sponsor's business decision, the clinical trial was terminated by the sponsor prematurely. No analysis was done at the termination of the trial, therefore, outcome, and safety data are not available and the numbers of participants analyzed are reported as "0".

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID